Pediatric 8.4% Sodium Bicarbonate Injection, Solution
Product Images NDC 51662-1472
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pediatric 8.4% Sodium Bicarbonate (NDC 51662-1472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (51662-1472-1 SERIALIZED CARTON LABELING)
51662-1472-1 Syringe Label (1472 Syringe Label)
This is a medical product for pediatric use that contains 8.4% Sodium Bicarbonate. It comes in a 10 mL single-dose form and has a usual dosage specified in the insert. The product is sterile, nonpyrogenic and is meant for intravenous use. The product has packaging graphics, and a label control approval. The manufacturing location of the product is Hospis, Lake Forest in the United States.*
51662-1463-1 Carton Label (Carton Labeling)
How Supplied (How Supplied)
51662-1463-1 Serialized Carton Labeling (Serialized Carton)
51662-1463-1 Syringe Label (Syringe Label)
This is a description of a medication product containing 7.5% Sodium Bicarbonate. It is available in a single-dose 50 mL injection, and the usual dosage can be found in the insert. It is a sterile and nonpyrogenic solution, and any unused portion should be discarded. The product is manufactured by Hospira, Inc., located in Lake Forest, IL, USA. The packaging includes graphics art and a label with control number D-395.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.